NutraLife BioSciences, Inc.
NLBS
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | 17.19% | 23.90% | -22.92% | -134.96% | -90.13% |
| Total Depreciation and Amortization | 27.99% | 7.15% | -5.79% | -17.30% | -28.05% |
| Total Amortization of Deferred Charges | -1.33% | 33.19% | 72.65% | -34.72% | -65.61% |
| Total Other Non-Cash Items | -36.36% | -46.78% | 12.64% | 739.52% | 1,621.95% |
| Change in Net Operating Assets | 319.19% | 201.21% | 1,217.41% | 3,287.85% | 325.23% |
| Cash from Operations | 49.96% | 54.34% | 51.68% | 62.05% | 4.48% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -39.06% | 81.08% | -54.82% | -16.50% | -15.48% |
| Total Debt Repaid | -1,201.52% | -457.07% | -225.13% | 3.08% | 27.47% |
| Issuance of Common Stock | -68.39% | 37.31% | 1,732.00% | 178.40% | 178.40% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | 19,400.00% | -- | -100.00% |
| Cash from Financing | 103.25% | 67.03% | 51.52% | 2.15% | 12.71% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 296.84% | 237.19% | -154.14% | 1,064.29% | 149.74% |
